Compare CECO & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CECO | PLSE |
|---|---|---|
| Founded | 1966 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pollution Control Equipment | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.5B |
| IPO Year | 2002 | 2015 |
| Metric | CECO | PLSE |
|---|---|---|
| Price | $62.33 | $19.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $77.75 | $22.00 |
| AVG Volume (30 Days) | ★ 528.7K | 250.3K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 280.56 | N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.84 | $840.00 |
| Revenue Next Year | $11.51 | $287.54 |
| P/E Ratio | $45.75 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.57 | $12.56 |
| 52 Week High | $81.72 | $26.30 |
| Indicator | CECO | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 53.73 | 42.34 |
| Support Level | $57.11 | $13.75 |
| Resistance Level | $64.12 | $20.40 |
| Average True Range (ATR) | 2.79 | 1.57 |
| MACD | 0.65 | -0.27 |
| Stochastic Oscillator | 79.71 | 10.35 |
CECO Environmental Corp is an industrial company, serving industrial air, industrial water, and energy transition markets. It offers various engineered and configured products and solutions, including dampers and diverters, selective catalytic reduction systems, severe-service and industrial cyclones, dust collectors, thermal oxidizers, filtration systems, wet and dry scrubbers, water treatment packages, industrial silencers, etc. These products are offered through brands like Western Airducts, WK, Wakefield Acoustics, Transcend, Verantis, and others. The company's reportable segments are: Engineered Systems, which derive maximum revenue, and Industrial Process Solutions. Geographically, it derives key revenue from the U.S., followed by the Netherlands, the UK, China, and other markets.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.